Brought to you by:
Boston Scientific completes acquisition of Silk Road Medical
Boston Scientific announced the close of its acquisition of Silk Road Medical, the company behind transcarotid artery revascularization (TCAR). “The integration of the TCAR platform into our portfolio means we can offer a treatment option for patients suffering from carotid artery disease that…
Smoking cessation remains a ‘ripe target’ for improved medication adherence in carotid disease
New data presented at the 2024 Vascular Annual Meeting (VAM) held June 19–22 in Chicago have revealed poor overall rates of medical therapy adherence in moderate asymptomatic carotid stenosis patients—with smoking cessation representing a “ripe target” for improvement moving forward.…
VAM 2024: Changes to carotid stenting landscape in United States set to be discussed
Sean P. Lyden, MD, chairman of the Department of Vascular Surgery at Cleveland Clinic’s Heart, Vascular and Thoracic Institute in Cleveland, Ohio, will discuss the national coverage determination (NCD) changes passed by the Centers for Medicare & Medicaid Services (CMS)…
New analysis points to lack of vascular surgical voices in news coverage of vascular disease
A new study set to be aired at the 2024 Society for Clinical Vascular Surgery (SCVS) annual meeting (March 16–20) in Scottsdale, Arizona, sheds a statistical spotlight on the state of the specialty’s reach into the mainstream consciousness. A team…
Single-center analysis suggests improved longer-term outcomes with endarterectomy versus TCAR
A large, single-center analysis has found that, despite parity between the two procedures in terms of perioperative clinical outcomes, carotid endarterectomy (CEA) was associated with a reduced rate of late stroke/death compared to transcarotid artery revascularization (TCAR). Writing in the…
Carotid stenting rebuttal: Those who live in glass houses…
Christopher J. White, MD, responds to a recent editorial by Malachi Sheahan III, MD, that took a critical look at the decision by the Centers for Medicare & Medicaid Services (CMS) to expand coverage for carotid artery stenting (CAS). I’m…
‘There is no reliable way to measure carotid stenosis—methods have changed and tend to overestimate the degree of narrowing’
The recent move to expand Medicare coverage of carotid stenting formed the basis of a recent debate over the wisdom of the decision taken by the Centers for Medicare & Medicaid Services (CMS). Two heavyweights in the stroke arena went…
New survey shows transcarotid artery revascularization patients report faster recovery than their endarterectomy counterparts
This advertorial is sponsored by Silk Road Medical. For Scott Berman, MD, patient responses when confronted with an explanation of the extent of their asymptomatic carotid disease tend to be quite stark. They are either so petrified of having a…
Carotid disease: Getting to the right decision
The recent move by the Centers for Medicare & Medicaid Services (CMS) to expand coverage for carotid artery stenting brought with it the requirement for a shared decision-making interaction between physicians and patients as they establish which carotid revascularization treatment…
CMS confirms broadened Medicare coverage of carotid artery stenting in final decision
The Centers for Medicare & Medicaid Services (CMS) has released its final decision regarding National Coverage Determination (NCD) 20.7 covering carotid artery stenting (CAS), essentially confirming the coverage expansion outlined in a July proposed decision memo. In a communique to…